{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:02:15Z","timestamp":1790262135239,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Glioblastoma (GBM) is the most prevalent and aggressive primary brain tumor in adults, with current therapies failing to achieve significant clinical advancements. GDPPH1, a natural compound derived from\n                    <jats:italic>Garcinia mangostana L<\/jats:italic>\n                    ., is known for its antioxidant properties; however, its anticancer effects and underlying mechanisms remain insufficiently understood. In this study, we demonstrate that GDPPH1 significantly inhibits GBM cell proliferation in a concentration-dependent manner by downregulating CDK4 and Cyclin D1 expression, inducing cell cycle arrest at G1\/S checkpoint, and promoting apoptosis. Mechanistically, GDPPH1 reduces the m\n                    <jats:sup>6<\/jats:sup>\n                    A methylation of\n                    <jats:italic>CDK4<\/jats:italic>\n                    and\n                    <jats:italic>CCND1<\/jats:italic>\n                    through METTL14-YTHDF2-mediated transcript decay, resulting in decreased\n                    <jats:italic>CDK4<\/jats:italic>\n                    \/\n                    <jats:italic>CCND1<\/jats:italic>\n                    expression and subsequent decreased RB phosphorylation levels. Further studies revealed that m\n                    <jats:sup>6<\/jats:sup>\n                    A-METTL14-YTHDF2 axis is responsible for GDPPH1-induced downregulation of CDK4 and Cyclin D1. Additionally, the in vivo anti-GBM efficacy of GDPPH1 was confirmed using both xenograft and orthotopic intracranial mouse models. Collectively, these findings provide robust evidence supporting GDPPH1 as a promising therapeutic candidate for GBM and offer novel insights into the role of m\n                    <jats:sup>6<\/jats:sup>\n                    A RNA methylation in cell cycle regulation.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-09036-x","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:45:30Z","timestamp":1783100730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GDPPH1 induces cell cycle arrest by downregulation of CDK4\/Cyclin D1 via the m6A-METTL14-YTHDF2 axis, attenuating glioblastoma progression"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9250-2026","authenticated-orcid":false,"given":"Sijia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9600-2162","authenticated-orcid":false,"given":"Jinxuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1977-4763","authenticated-orcid":false,"given":"Ruxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2700-9476","authenticated-orcid":false,"given":"Xinyi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0179-0641","authenticated-orcid":false,"given":"Lele","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4047-6228","authenticated-orcid":false,"given":"Xiaofeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6515-8941","authenticated-orcid":false,"given":"Qiuming","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7594-0892","authenticated-orcid":false,"given":"Zhijing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3367-2139","authenticated-orcid":false,"given":"Siyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0725-4519","authenticated-orcid":false,"given":"Jianqin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1921-6532","authenticated-orcid":false,"given":"Xiaosong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zepeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4999-9663","authenticated-orcid":false,"given":"Yu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4460-0713","authenticated-orcid":false,"given":"Qi","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"9036_CR1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 2023;329:574\u201387.","journal-title":"JAMA"},{"key":"9036_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40164-024-00512-8","volume":"13","author":"Y Shen","year":"2024","unstructured":"Shen Y, Thng DKH, Wong ALA, Toh TB. Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review. Exp Hematol Oncol. 2024;13:40.","journal-title":"Exp Hematol Oncol"},{"key":"9036_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41392-024-01763-x","volume":"9","author":"Y Yan","year":"2024","unstructured":"Yan Y, Zhou S, Chen X, Yi Q, Feng S, Zhao Z, et al. Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis. Signal Transduct Target Ther. 2024;9:58.","journal-title":"Signal Transduct Target Ther"},{"key":"9036_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309290","volume":"11","author":"Q Yue","year":"2024","unstructured":"Yue Q, Wang Z, Shen Y, Lan Y, Zhong X, Luo X, et al. Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2-Mediated MLH1 Intron Retention. Adv Sci. 2024;11:e2309290.","journal-title":"Adv Sci"},{"key":"9036_CR5","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1200\/JCO-25-00618","volume":"43","author":"AB Lassman","year":"2025","unstructured":"Lassman AB, Polley MC, Iwamoto FM, Sloan AE, Wang TJC, Aldape KD, et al. Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II\/III Clinical Trial. J Clin Oncol. 2025;43:3032\u201340.","journal-title":"J Clin Oncol"},{"key":"9036_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155140","volume":"122","author":"J Li","year":"2024","unstructured":"Li J, Nie X, Panthakarn R, Wu X, Zheng C, Cheng Y, et al. Structure and activity relationship analysis of xanthones from mangosteen: Identifying garcinone E as a potent dual EGFR and VEGFR2 inhibitor. Phytomedicine. 2024;122:155140.","journal-title":"Phytomedicine"},{"key":"9036_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106032","volume":"175","author":"MC Nauman","year":"2022","unstructured":"Nauman MC, Johnson JJ. The purple mangosteen (Garcinia mangostana): Defining the anticancer potential of selected xanthones. Pharm Res. 2022;175:106032.","journal-title":"Pharm Res"},{"key":"9036_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12906-024-04450-0","volume":"24","author":"W Nittayananta","year":"2024","unstructured":"Nittayananta W, Srichana T, Chuerduangphui J, Hitakomate E, Netsomboon K. Formulation of 1% \u03b1-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma. BMC Complement Med Ther. 2024;24:276.","journal-title":"BMC Complement Med Ther"},{"key":"9036_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107968","volume":"153","author":"M Fredimoses","year":"2024","unstructured":"Fredimoses M, Li P, Zhang Y, Jia H, Liu S, Tian J, et al. Design, synthesis, and antiproliferative activity evaluation of novel \u03b1-mangostin derivatives by ROS\/MAPK signaling pathway. Bioorg Chem. 2024;153:107968.","journal-title":"Bioorg Chem"},{"key":"9036_CR10","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1021\/jf8032683","volume":"57","author":"SH Hung","year":"2009","unstructured":"Hung SH, Shen KH, Wu CH, Liu CL, Shih YW. Alpha-mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2\/9 and urokinase-plasminogen expression through the JNK signaling pathway. J Agric Food Chem. 2009;57:1291\u20138.","journal-title":"J Agric Food Chem"},{"key":"9036_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-69","volume":"9","author":"MA Shibata","year":"2011","unstructured":"Shibata MA, Iinuma M, Morimoto J, Kurose H, Akamatsu K, Okuno Y, et al. \u03b1-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation. BMC Med. 2011;9:69.","journal-title":"BMC Med"},{"key":"9036_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20:303\u201322.","journal-title":"Nat Rev Cancer"},{"key":"9036_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1033-z","volume":"18","author":"XY Chen","year":"2019","unstructured":"Chen XY, Zhang J, Zhu JS. The role of m(6)A RNA methylation in human cancer. Mol Cancer. 2019;18:103.","journal-title":"Mol Cancer"},{"key":"9036_CR14","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/neuonc\/noy072","volume":"20","author":"A Karachi","year":"2018","unstructured":"Karachi A, Dastmalchi F, Mitchell DA, Rahman M. Temozolomide for immunomodulation in the treatment of glioblastoma. Neuro-Oncol. 2018;20:1566\u201372.","journal-title":"Neuro-Oncol"},{"key":"9036_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21:14.","journal-title":"Mol Cancer"},{"key":"9036_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/jnen\/nlaf090","volume":"85","author":"Z Zhang","year":"2026","unstructured":"Zhang Z, Guo X, Qi T, Wang C, Zhai X, Wang M. METTL14\/IGF2BP2-mediated m6A modification of PD-L1 promotes proliferation, metastasis, and immune escape in high-grade gliomas. J Neuropathol Exp Neurol. 2026;85:39\u201349.","journal-title":"J Neuropathol Exp Neurol"},{"key":"9036_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13046-024-03038-3","volume":"43","author":"P Yu","year":"2024","unstructured":"Yu P, Xu T, Ma W, Fang X, Bao Y, Xu C, et al. PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt-\u03b2-catenin pathway. J Exp Clin Cancer Res. 2024;43:116.","journal-title":"J Exp Clin Cancer Res"},{"key":"9036_CR18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1158\/2159-8290.CD-20-0331","volume":"11","author":"D Dixit","year":"2021","unstructured":"Dixit D, Prager BC, Gimple RC, Poh HX, Wang Y, Wu Q, et al. The RNA m6A reader YTHDF2 maintains oncogene expression and is a targetable dependency in glioblastoma stem cells. Cancer Discov. 2021;11:480\u201399.","journal-title":"Cancer Discov"},{"key":"9036_CR19","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","volume":"18","author":"Q Cui","year":"2017","unstructured":"Cui Q, Shi H, Ye P, Li L, Qu Q, Sun G, et al. m(6)A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells. Cell Rep. 2017;18:2622\u201334.","journal-title":"Cell Rep"},{"key":"9036_CR20","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061\u20138.","DOI":"10.1038\/nature07385"},{"key":"9036_CR21","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.3390\/ijms25042343","volume":"25","author":"K Liu","year":"2024","unstructured":"Liu K, Zhou X, Li C, Shen C, He G, Chen T, et al. YTHDF2 as a mediator in BDNF-induced proliferation of porcine follicular granulosa cells. Int J Mol Sci. 2024;25:2343.","journal-title":"Int J Mol Sci"},{"key":"9036_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.canlet.2017.08.030","volume":"408","author":"S Wang","year":"2017","unstructured":"Wang S, Sun C, Li J, Zhang E, Ma Z, Xu W, et al. Roles of RNA methylation by means of N(6)-methyladenosine (m(6)A) in human cancers. Cancer Lett. 2017;408:112\u201320.","journal-title":"Cancer Lett"},{"key":"9036_CR23","first-page":"150","volume":"56","author":"K Ueki","year":"1996","unstructured":"Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN. CDKN2\/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res. 1996;56:150\u20133.","journal-title":"Cancer Res"},{"key":"9036_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp5332","volume":"10","author":"L Cui","year":"2024","unstructured":"Cui L, Wu Y, Chen Z, Li B, Cai J, Chang Z, et al. N6-methyladenosine modification-tuned lipid metabolism controls skin immune homeostasis via regulating neutrophil chemotaxis. Sci Adv. 2024;10:eadp5332.","journal-title":"Sci Adv"},{"key":"9036_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.2337\/db22-0775","volume":"72","author":"R Xie","year":"2023","unstructured":"Xie R, Yan S, Zhou X, Gao Y, Qian Y, Hou J, et al. Activation of METTL3 promotes white adipose tissue beiging and combats obesity. Diabetes. 2023;72:1083\u201394.","journal-title":"Diabetes"},{"key":"9036_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.","journal-title":"Signal Transduct Target Ther"},{"key":"9036_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40164-022-00298-7","volume":"11","author":"Z Fang","year":"2022","unstructured":"Fang Z, Mei W, Qu C, Lu J, Shang L, Cao F, et al. Role of m6A writers, erasers and readers in cancer. Exp Hematol Oncol. 2022;11:45.","journal-title":"Exp Hematol Oncol"},{"key":"9036_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1162607","volume":"14","author":"L Chen","year":"2023","unstructured":"Chen L, Gao Y, Xu S, Yuan J, Wang M, Li T, et al. N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms. Front Immunol. 2023;14:1162607.","journal-title":"Front Immunol"},{"key":"9036_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41420-022-00939-0","volume":"8","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chen J, Gao WQ, Yang R. METTL14 promotes prostate tumorigenesis by inhibiting THBS1 via an m6A-YTHDF2-dependent mechanism. Cell Death Discov. 2022;8:143.","journal-title":"Cell Death Discov"},{"key":"9036_CR30","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41586-024-08224-z","volume":"636","author":"YJ Chen","year":"2024","unstructured":"Chen YJ, Iyer SV, Hsieh DC, Li B, Elias HK, Wang T, et al. Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma. Nature. 2024;636:466\u201373.","journal-title":"Nature"},{"key":"9036_CR31","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.3390\/nu16152389","volume":"16","author":"A Giammona","year":"2024","unstructured":"Giammona A, Commisso M, Bonanomi M, Remedia S, Avesani L, Porro D, et al. A novel strategy for glioblastoma treatment by natural bioactive molecules showed a highly effective anti-cancer potential. Nutrients. 2024;16:2389.","journal-title":"Nutrients"},{"key":"9036_CR32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/antiox14030351","volume":"14","author":"A Nowacka","year":"2025","unstructured":"Nowacka A, Zi\u00f3\u0142kowska E, Smuczy\u0144ski W, Bo\u017ci\u0142ow D, \u015aniegocki M. Potential of Curcumin and its analogs in glioblastoma therapy. Antioxidants. 2025;14:351.","journal-title":"Antioxidants"},{"key":"9036_CR33","doi-asserted-by":"publisher","first-page":"e0344872","DOI":"10.1371\/journal.pone.0344872","volume":"21","author":"B Liu","year":"2026","unstructured":"Liu B, Peng D, Chen Y, Li Q, Hu Y, Liu S, et al. Multi-omics analysis identifies CCNB1 as a cell cycle factor driving glioblastoma progression and its inhibition by resveratrol. PLoS One. 2026;21:e0344872.","journal-title":"PLoS One"},{"key":"9036_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1712599","volume":"16","author":"D Elsori","year":"2025","unstructured":"Elsori D, Alshabrmi FM, Alharbi AM, Saeed M, Singh A, Pandey P, et al. Anticancer potential of natural bioactive compounds saponins in glioblastoma multiforme. Front Pharm. 2025;16:1712599.","journal-title":"Front Pharm"},{"key":"9036_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.848","volume":"12","author":"C-S Huang","year":"2022","unstructured":"Huang C-S, Zhu Y-Q, Xu Q-C, Chen S, Huang Y, Zhao G, et al. YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation. Clin Transl Med. 2022;12:e848.","journal-title":"Clin Transl Med"},{"key":"9036_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11060-025-05315-3","volume":"176","author":"B Hsueh","year":"2025","unstructured":"Hsueh B, Steuart SJ, Odukoya AO, Prager BC, Kim YJ, Hill CM, et al. Immunotherapy and targeted therapy for high grade gliomas: current and future directions. J Neurooncol. 2025;176:112.","journal-title":"J Neurooncol"},{"key":"9036_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1393","volume":"11","author":"Y Chen","year":"2022","unstructured":"Chen Y, Wang YL, Qiu K, Cao YQ, Zhang FJ, Zhao HB, et al. YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the Akt and NF-\u03baB signalling pathways via inhibiting EPHB3 and TNFAIP3. Clin Transl Immunol. 2022;11:e1393.","journal-title":"Clin Transl Immunol"},{"key":"9036_CR38","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.21037\/tau-23-682","volume":"13","author":"X Zhong","year":"2024","unstructured":"Zhong X, Wang S, Yang X, Yang X, Zhou L. METTL14 inhibits the proliferation, migration and invasion of prostate cancer cells by increasing m6A methylation of CDK4. Transl Androl Urol. 2024;13:1145\u201363.","journal-title":"Transl Androl Urol"},{"key":"9036_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102395","volume":"56","author":"J Zheng","year":"2025","unstructured":"Zheng J, Liang Y, Xu X, Zhou J, Jiang S, Yu J. N6-methyladenosine binding protein YTHDF2 inhibits gastric cancer cell growth and predicts better prognosis in patients with gastric cancer. Transl Oncol. 2025;56:102395.","journal-title":"Transl Oncol"},{"key":"9036_CR40","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202256325","volume":"24","author":"Y Hou","year":"2023","unstructured":"Hou Y, Zhang X, Yao H, Hou L, Zhang Q, Tao E, et al. METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53-wild-type cells. EMBO Rep. 2023;24:e56325.","journal-title":"EMBO Rep"},{"key":"9036_CR41","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1016\/j.molcel.2021.10.028","volume":"81","author":"J Wei","year":"2021","unstructured":"Wei J, Harada BT, Lu D, Ma R, Gao B, Xu Y, et al. HRD1-mediated METTL14 degradation regulates m(6)A mRNA modification to suppress ER proteotoxic liver disease. Mol Cell. 2021;81:5052\u201365.e5056.","journal-title":"Mol Cell"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09036-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09036-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09036-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:03:08Z","timestamp":1790258588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09036-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9036"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09036-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"9 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All experiments involving mice were performed in accordance with the guidelines of the Jinan University Institutional Animal Care and Use Committee.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"828"}}